Ansun Biopharma

CA 2026 Independent Pharmacies

OIG False Claims

Penalty

$2 million

Outcome

OIG enforcement action against Ansun Biopharma for false claims. Penalty: $2 million.

Details

Ansun Biopharma — OIG Enforcement (2026)

OIG took enforcement action against Ansun Biopharma in CA in 2026 involving false claims violations in the Independent Pharmacies sector.

Penalty: $2 million

Violation types: False Claims
Entity type: Pharmacy
Penalty type: Criminal
Location: CA

Source: Ansun Biopharma to Pay More Than $2 Million for Overbilling the U.S.

How Crucible Prevents This

Crucible's billing compliance controls enforce documentation-to-claims reconciliation, requiring clinical attestation before claims submission and flagging billing patterns that deviate from documented care delivery.

Source: Ansun Biopharma to Pay More Than $2 Million for Overbilling the U.S.

Don't let this happen to your organization. See how Crucible works.

See How Crucible Works